Vertex Pharma (VRTX) April 430 and 440 puts active

Vertex Pharma (NASDAQ: VRTX) 30-day option implied volatility is at 29; compared to its 52-week range of 18 to 334into acquiring Alpine Immune Sciences (ALPN) for $65 per share. Call put ratio 1 call to 6.2 puts with focus on April 430 and 440 puts.

You May Also Be Interested In

• SpaceX (SPCX) call put ratio 2 calls to 1 put as share price at $160
• Sandisk (SNDK) call put ratio 1.2 calls to 1 put as share price down 10.5%
• Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia